Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis
The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An increased prevalence of functional hyperandrogenism—including polycystic ovary syndrome (PCOS)—has been described in women with type 1 diabetes (T1D). However, heterogeneity between studies is frequent, and prevalence rates vary according to different criteria used for the diagnosis of PCOS and the population studied. OBJECTIVE AND RATIONALE: We aimed to perform a systematic review and meta-analysis of the prevalence of PCOS and related hyperandrogenic traits in premenopausal women with T1D. This way, we intend to increase the precision of the estimates of prevalence of PCOS and related traits in women with T1D, and to explore sources of heterogeneity while providing prevalence estimates for clinically relevant subgroups such as the different phenotypes. SEARCH METHODS: We conducted a systematic review of the literature using Medline-OVID and Embase databases (Open Science Framework registry for systematic review protocols, https://osf.io/6cv9p/). Studies published up to 29 March 2021 were considered. We selected cross-sectional or prospective studies that reported, in patients with T1D, prevalence data on PCOS according to current definitions and different phenotypes, and/or prevalence rates of other related traits (hirsutism, hyperandrogenaemia, oligo-amenorrhoea and/or polycystic ovarian morphology: PCOM). Exclusion criteria for the review were studies addressing types of diabetes other than T1D; and studies using diagnostic definitions of PCOS different than those mentioned above. Two independent researchers performed data extraction. To assess the risk of bias, we used a tool developed specifically to appraise population-based prevalence studies. OUTCOMES: We selected 19 studies (1042 women) reporting the prevalence of PCOS and/or other hyperandrogenic traits. Regarding bias, 12 studies were considered of low-risk, and the remaining seven studies were considered intermediate risk. The pooled prevalence of PCOS when considering all possible phenotypes (ESHRE- American Society for Reproductive Medicine criteria) in T1D was 26% (95% CI: 19–34%; 13 studies, 684 women). Pooled prevalence of classic PCOS (US National Institutes of Health criteria) was 16% (95% CI: 10–22%; 9 studies, 614 women). Pooled prevalence of hyperandrogenic PCOS (Androgen Excess and PCOS Society criteria) was 26% (95% CI: 16–41%; 5 studies, 329 women). Hirsutism (24%), hyperandrogenaemia (29%), oligomenorrhoea (24%) and PCOM (34%) were also prevalent. Heterogeneity was high in almost all these meta-analyses. WIDER IMPLICATIONS: This systematic review and meta-analysis showed that PCOS and related hyperandrogenic traits are present in approximately one in every four women with T1D. Larger studies are needed to confirm this association, to address the effect of different variables on the occurrence of PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Type 1 diabetes has been observed to have a higher prevalence (7%-25%) in those with PCOS, and in those with menstrual and reproductive dysfunction, and this has been associated with hyperandrogenemia.110, 111, 112, 113, 114”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [113]
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003583 · Cited by 5,148
Hoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Self-citationPolycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Self-citationAsunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Self-citationThe Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Asuncion, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2434 · Cited by 791
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
Self-citation
Research works printed but not linked: 6
- Calliari, 2014, Polycystic ovary syndrome and hyperandrogenism in type 1 diabetes: Adolescent girls are already at risk, Pediatr Diabetes, 15, 106
- Dabadghao, 2016, Prevalence of polycystic ovary syndrome and its clinical profile in young females with type 1 diabetes mellitus, Horm Res Paediatr, 86, 238
- Deja, 2010, Clinical and hormonal profile in adolescent girls with type 1 diabetes mellitus and polycystic vary syndrome or polycystic ovary morphology, Pediatr Diabetes, 11, 20
- Deja, 2009, PCOS and hyperandrogenic disorders—a problem in adolescent girls with type 1 diabetes mellitus and good metabolic control, Pediatr Diabetes, 10, 99
- Kvasnickova, 2010, Occurrence of polycystic ovary syndrome and hyperadrogenemia in women with type 1 diabetes mellitus, Prakt Lek, 90, 224
- Zawadzki, 1992, Polycystic Ovary Syndrome, 377
Cited by
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
“113,115”
Myo-inositol in assisted reproductive technology from bench to bedside
Etrusco, A., Laganà, A. S., Chiàntera, V., Buzzaccarini, G., & Unfer, V. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.005 · Cited by 48
Dou, Y., Zhang, M., Zhang, H., Zhang, C., Feng, L., Hu, J., Gao, Y., Yuan, X.-Z., Zhao, Y., Zhao, H., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174972 · Cited by 43
Gonadal dysfunction in women with diabetes mellitus
Zaimi, M., Michalopoulou, O., Stefanaki, K., Kazakou, P., Vasileiou, V., Ψαλτοπούλου, Θ., Karagiannakis, D. S., & Paschou, S. Α. (2024) · Endocrine · doi:10.1007/s12020-024-03729-z · Cited by 35
He, J., Deng, R., Wei, Y., Zhang, S., Su, M., Tang, M., Wang, J., Nong, W., & Lei, X. (2024) · Food & Function · doi:10.1039/d3fo02824k · Cited by 26
Investigation of Prevalence and Awareness of Polycystic Ovary Syndrome among Pakistani Females
Zulfiqar, S., Tahir, S., Gulraiz, S., Razzaq, M. A., Abid, A., Shahid, T., Babar, A., Rehman, B., Rafique, H., Noor, S., et al. (2022) · Proceedings of the Pakistan Academy of Sciences B Life and Environmental Sciences · doi:10.53560/ppasb(59-1)703 · Cited by 23
Barberis, N., Calaresi, D., Cannavò, M., & Verrastro, V. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.962083 · Cited by 23
Dokras, A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2025) · Reproduction · doi:10.1530/rep-25-0118 · Cited by 21
Self-citationLin, Y., Zeng, H., Lin, J., Peng, Y., Que, X., Wang, L., Chen, L., & Bai, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1328741 · Cited by 18
Mesa, A., Franch‐Nadal, J., Navas, E., & Mauricio, D. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02791-9 · Cited by 16
Gadhave, P. V., Sutar, G., Sajane, S. J., Redasani, V. K., Das, K., Dharani Prasad, P., Alobid, S. E., Almoteer, A. I., Rabbani, S. I., Yasmin, F., et al. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.101953 · Cited by 11
Liang, R., Sheng, M., Li, X., Jin, J., & Yi, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116551 · Cited by 10
Isatin ameliorates ovarian inflammation and apoptosis caused by hormonal imbalances in PCOS mice
Li, X., Ye, T., Zhu, W., Gu, J., Zheng, Z., Wang, C., Zhang, X., Geng, H., Zhou, W., Tan, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117083 · Cited by 9
Kwiatkowski, J., Akpang, N., Ziemkiewicz, Z., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178192 · Cited by 7
Progress of the application clinical prediction model in polycystic ovary syndrome
Guan, G., Yifu, P., Yuan, G., Xialei, L., Shi, F., Sun, Q., Jinjin, X., Linna, Z., Xiaozuo, Z., Wen, F., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01310-2 · Cited by 7
Chen, S., Guo, Z., & Yu, Q. (2023) · Human Genomics · doi:10.1186/s40246-023-00550-z · Cited by 6
Jiang, Y., Li, Y.-Q., & Huang, Y. (2025) · Medicine · doi:10.1097/md.0000000000041359 · Cited by 6
Hu, X., Zhu, M., Zhou, Q., Li, Z., Luo, L., Liang, W., Chen, S., Pu, X., & Du, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s574929 · Cited by 5
Cebada, A. B., Nattero‐Chávez, L., de la Villa, E. D. L. C., Tobar, A. Q., Quiñones, S. D. L., Avendaño, B. D., Fiers, T., Jean-Marc, K., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2025) · Human Reproduction Open · doi:10.1093/hropen/hoaf048 · Cited by 4
Self-citationQasim, A., Calvo, H., Escobar, J. J. M., & Akhtar, Z.-U.-D. (2025) · Biology · doi:10.3390/biology14070903 · Cited by 4
Functional and Structural Uterine Changes in PCOS
Zaborowska, Ł., Blok, J., Piotrkowicz, E., Lindheim, S. R., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167921 · Cited by 4
Hu, K.-L., Liao, T., Wu, Q., Ma, X., Cao, Y., Tan, J., Tian, L., Wang, J., Yin, J., Liu, Y., et al. (2026) · BMJ · doi:10.1136/bmj-2025-087438 · Cited by 4
Liang, Z., Zhang, Q., Liu, Y., Liu, Z., Jiang, Y., Yang, X., Wei, L., & Wang, G. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114647 · Cited by 4
Pepa, G. D., Lupoli, R., Masulli, M., Boccia, R., Angelis, R. D., Gianfrancesco, S., Rainone, C., Rivellese, A. A., Annuzzi, G., & Bozzetto, L. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110816 · Cited by 4
Waqar, M. A., Mubarak, N., & Khan, R. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02087-7 · Cited by 3
Lyu, Y., Cai, L., & Li, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1609131 · Cited by 2
Glintborg, D., Møller, J. K., Rubin, K. H., Christensen, L. L., & Andersen, M. (2025) · Clinical Endocrinology · doi:10.1111/cen.70019 · Cited by 2
Yassin, M. M., Laqqan, M. M., Mwafy, S. N., & El-qreenawy, S. I. (2024) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00150-w · Cited by 2
Nguyen, N. T., Ho, V. N. A., Pham, T. D., Nguyen, M. H. N., Nguyen, D. L., Le, L. H., Le, K. T. Q., Lý, Đ. L., Tran, M. T. N., Ho, T. M., et al. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag012 · Cited by 1
Autoimmune diseases in patients with different PCOS phenotypes
Robeva, R. N., Кirilov, G., Kalinov, K., & Elenkova, A. P. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1806450 · Cited by 1
Urhan, E., Elbüken, G., Hacıoğlu, A., Karaca, Z., Unluhizarci, K., & Keleştimur, F. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01946-9 · Cited by 1
Awareness of Polycystic Ovarian Syndrome among Jordanian Females
Barrouq, D. M. S., Alazawa, Z. F. R., & Irshaidat, T. (2023) · Open Access Indonesian Journal of Medical Reviews · doi:10.37275/oaijmr.v3i3.315 · Cited by 1
Nattero‐Chávez, L., Bondía, J., Escobar-Morreale, H. F., & Luque‐Ramírez, M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13515 · Cited by 1
Self-citationToama, E. A., & Jasim, H. A. (2023) · Bionatura · doi:10.21931/rb/css/2023.08.02.10
Polycystic Ovary Syndrome and Type 1 Diabetes in Pregnancy
Dolatabadi, S., Yamamoto, J. M., & Benham, J. L. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2024.102363
Endocrine Abnormalities and Their Relationship with Menstrual Irregularities: A Meta-analysis
Qi, X. (2024) · MEDS Public Health and Preventive Medicine · doi:10.23977/phpm.2024.040208
Screening analysis of the prevalence of leading endocrine diseases in Tajikistan
Niyazova, N. F. (2024) · Health care of Tajikistan · doi:10.52888/0514-2515-2024-361-2-51-55
Guerra, A. L., Fernández, E. F., Cebrián, S. B., & Albarrán, O. G. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.09.004
Sharma, P., Mittal, P., & Arya, G. C. (2024) · Current Analytical Chemistry · doi:10.2174/0115734110312022240903060337
Proinflammatory markers in women with type 1 diabetes and polycystic ovary syndrome
García-Sáenz, M. R., López-Juárez, N., Valencia‐Ortega, J., Saucedo, R., Lobaton-Ginsberg, M., Ramírez‐Rentería, C., León-Wu, K. S., Sosa, E., Espinosa-Cárdenas, E., & Ferreira‐Hermosillo, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-25070-9
Kim, C., Bellatorre, A., Reynolds, K., Dolan, L. M., Pihoker, C., Yin, Z., Huddleston, H. G., Snell‐Bergeon, J. K., & Dabelea, D. (2025) · Journal of Women s Health · doi:10.1177/15409996251405799
Chen, S., Guo, Z., & Yu, Q. (2023) · Figshare · doi:10.6084/m9.figshare.24558172
Chen, S., Guo, Z., & Yu, Q. (2024) · Figshare · doi:10.6084/m9.figshare.24558199
Kurniawati, E. Y., & Noviasari, E. (2026) · Jurnal Riset Daerah · doi:10.64730/jrdbantul.v26i1.161
Diagnosis and management of androgen excess presenting after menopause
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.109037
Self-citationOttey, S., Pokuah, F., Cree, M. G., Sherif, K., Vesper, H. W., Lyle, A. N., & Azziz, R. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag276
Loaiza-Giraldo, J. P., Valdivia-Arroyo, R., Greve-Quezada, V., Quivira-Muñoz, A., Silva-Perez, O., Tocornal, T. S., Bruna-Mejías, A., Nova-Baeza, P., Orellana-Donoso, M., Moya, M. P., et al. (2026) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2026.109439
Bayona, A., Vega‐Beyhart, A., Insenser, M. R., Martínez-García, M. Á., Nattero‐Chávez, L., de la Villa, E. D. L. C., Avendaño, B. D., Fiers, T., Kaufman, J., Escobar-Morreale, H. F., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-62157-3
Self-citationKurniasari, L., & Zulaikha, F. (2026) · Jurnal Ilmiah Kesehatan (JIKA) · doi:10.36590/jika.v8i2.2089
Ugli, T. T. B. (2025) · Web of Medicine: Journal of Medicine, Practice and Nursing
Georgy, S. M., Elnaidany, N. F., Abdelmoneum, N. A., Salem, S. A. M., Salem, H. F., & Sarhan, R. M. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10995-z
Toft, S., Ekberg, N. R., Abdulrahim, H., Gidlöf, S. B., Rössner, S. M., Trouva, A., Öberg, E., Catrina, S., Hirschberg, A. L., & Alvarsson, M. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag256
Metadata
- Authors
- Bayona, A., Martínez-Vaello, V., Zamora, J., Nattero-Chávez, L., Luque-Ramírez, M., & Escobar-Morreale, H. F.
- Affiliations
- Universidad de Alcalá (ES)
- Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal , Madrid, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-03
- Volume
- 28
- Issue
- 4
- Pages
- 501-517
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W4212965655
- Cited by
- 44
- References
- 46
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 10 · 2023: 9 · 2022: 3
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Instituto de Salud Carlos III (PIE16/00050)
- European Development Regional Fund ‘A way (CM19/00138)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- polycystic ovary syndrome, type 1 diabetes, hyperandrogenism, PCOS phenotypes, hirsutism, hyperandrogenemia, polycystic ovary morphology, prevalence, premenopausal women, NIH criteria
- MeSH terms
- Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Hirsutism, Humans, Phenotype, Polycystic Ovary Syndrome, Prospective Studies, Prevalence, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.